AETHLON MEDICAL INC 8-K

What Happened

• Aethlon Medical, Inc. (AEMD) filed an 8-K on Feb 23, 2026 reporting two governance actions. The company amended its Articles of Incorporation to increase authorized common stock from 6,000,000 shares to 100,000,000 shares (Certificate of Amendment attached as Exhibit 3.1).
• Separately, stockholders approved an amendment to Aethlon’s 2020 Equity Incentive Plan to add 100,000 shares for future grants; the Board had approved the Plan Amendment on Dec 2, 2025 and it became effective Feb 19, 2026. The Amended 2020 Plan is attached as Exhibit 10.1.

Key Details

• Authorized common shares increased from 6,000,000 to 100,000,000 (Articles Amendment).
• Equity plan increase: 100,000 additional common shares authorized under the 2020 Equity Incentive Plan.
• Board approval date for the Plan Amendment: Dec 2, 2025; stockholder approval/effective date: Feb 19, 2026.
• Exhibits: Certificate of Amendment (Exhibit 3.1) and the Amended 2020 Equity Incentive Plan (Exhibit 10.1).

Why It Matters

• Increasing authorized shares provides the company flexibility to issue more stock for financing, acquisitions, or other corporate purposes; it does not itself issue shares but enables future issuances that can dilute existing shareholders.
• Expanding the equity incentive plan allows Aethlon to grant more stock-based awards to employees, directors, or consultants, which can help attract and retain talent but may also dilute current shareholders if awards are issued.
• No earnings, management changes, or immediate financings were reported in this 8-K—these are corporate governance changes that set up potential future actions.